Drugs / diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004800 | Sep 1992 → ? | pertussis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004800 ↗ |
| Modality | Vaccine | “diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis” NCT00004800 ↗ |
| Route | Intramuscular | “All vaccines are administered as an intramuscular or deep subcutaneous injection” NCT00004800 ↗ |
| Route | Subcutaneous | “All vaccines are administered as an intramuscular or deep subcutaneous injection” NCT00004800 ↗ |